共 13 条
[1]
癌组织浸润的FoxP3~+调节性T淋巴细胞与CD34表达及肝癌患者的预后相关.[J].黄勇;王凤梅;王涛;王毅军;朱争艳;高英堂;杜智;.中华肝脏病杂志.2012, 01
[2]
[3]
慢性HBV感染的免疫治疗.[J].于贤杰;王贵强;.世界华人消化杂志.2007, 16
[4]
[7]
Intrahepatic interleukin‐17<sup>+</sup> T cells and F ox P 3<sup>+</sup> regulatory T cells cooperate to promote development and affect the prognosis of hepatocellular carcinoma.[J].Yong Huang;Fengmei Wang;Yijun Wang;Zhengyan Zhu;Yingtang Gao;Zhe Ma;Ruicheng Xu;Zhi Du.J Gastroenterol Hepatol.2014, 4
[8]
Telbivudine treatment is associated with high hepatitis B e antigen seroconversion and immune modulatory effects in chronic hepatitis B patients.[J].G.‐Q. Wang;Y.‐P. Ding;Y.‐H. Dong.J Viral Hepat.2013,
[9]
Metabolic control of the Treg/Th17 axis.[J].Joseph Barbi;Drew Pardoll;Fan Pan.Immunol Rev.2013, 1
[10]
Treatment of HBV related cirrhosis.[J].Florian B?mmel;Thomas Berg.Liver Int.2013,

